Lipocine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lipocine and other ETFs, options, and stocks.About LPCN
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy.
CEOMahesh V. Patel
CEOMahesh V. Patel
Employees16
Employees16
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2011
Founded2011
Employees16
Employees16
LPCN Key Statistics
Market cap23.93M
Market cap23.93M
Price-Earnings ratio-4.18
Price-Earnings ratio-4.18
Dividend yield—
Dividend yield—
Average volume103.40K
Average volume103.40K
High today$4.35
High today$4.35
Low today$4.14
Low today$4.14
Open price$4.23
Open price$4.23
Volume102.57K
Volume102.57K
52 Week high$5.50
52 Week high$5.50
52 Week low$2.52
52 Week low$2.52
Stock Snapshot
With a market cap of 23.93M, Lipocine(LPCN) trades at $4.25. The stock has a price-to-earnings ratio of -4.18.
During the trading session on 2025-12-21, Lipocine(LPCN) shares reached a daily high of $4.35 and a low of $4.14. At a current price of $4.25, the stock is +2.7% higher than the low and still -2.3% under the high.
Trading volume for Lipocine(LPCN) stock has reached 102.57K, versus its average volume of 103.4K.
The stock's 52-week range extends from a low of $2.52 to a high of $5.50.
The stock's 52-week range extends from a low of $2.52 to a high of $5.50.
People also own
Based on the portfolios of people who own LPCN. This list is generated using Robinhood data, and it’s not a recommendation.